116 related articles for article (PubMed ID: 12876016)
1. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications.
Kalra MK; Maher MM; Boland GW; Saini S; Fischman AJ
AJR Am J Roentgenol; 2003 Aug; 181(2):387-93. PubMed ID: 12876016
[No Abstract] [Full Text] [Related]
2. Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Kim J; Quon A; Humke E; Ford JM; Koong AC
Clin Nucl Med; 2009 May; 34(5):312-3. PubMed ID: 19387214
[No Abstract] [Full Text] [Related]
3. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.
Cook GJ; Wegner EA; Fogelman I
Semin Nucl Med; 2004 Apr; 34(2):122-33. PubMed ID: 15031812
[TBL] [Abstract][Full Text] [Related]
4. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
Voth M; Opfermann T; Gottschild D
Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634
[TBL] [Abstract][Full Text] [Related]
5. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
6. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
Inokuma T; Tamaki N; Torizuka T; Magata Y; Fujii M; Yonekura Y; Kajiyama T; Ohshio G; Imamura M; Konishi J
Radiology; 1995 May; 195(2):345-52. PubMed ID: 7724751
[TBL] [Abstract][Full Text] [Related]
8. The role of positron emission tomography in the management of pancreatic cancer.
Pakzad F; Groves AM; Ell PJ
Semin Nucl Med; 2006 Jul; 36(3):248-56. PubMed ID: 16762614
[TBL] [Abstract][Full Text] [Related]
9. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.
Lemke AJ; Niehues SM; Hosten N; Amthauer H; Boehmig M; Stroszczynski C; Rohlfing T; Rosewicz S; Felix R
J Nucl Med; 2004 Aug; 45(8):1279-86. PubMed ID: 15299049
[TBL] [Abstract][Full Text] [Related]
10. PET/CT in diagnostic oncology.
Messa C; Bettinardi V; Picchio M; Pelosi E; Landoni C; Gianolli L; Gilardi MC; Fazio F
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):66-75. PubMed ID: 15243404
[TBL] [Abstract][Full Text] [Related]
11. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
12. [18FDG-PET imaging of pancreatic adenocarcinoma].
Daenen F; Hustinx R; Belhocine T; Focan C; Honoré P; Rigo P
Rev Med Liege; 2000 Feb; 55(2):89-94. PubMed ID: 10769575
[TBL] [Abstract][Full Text] [Related]
13. [Can the extent of pancreatic tumors be evaluated reliably enough by positron emission tomography (PET)].
Sendler A; Avril N; Roder JD; Schwaiger M; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1485-7. PubMed ID: 9931919
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic tumors: imaging with PET.
Hawkins RA
Radiology; 1995 May; 195(2):320-2. PubMed ID: 7724745
[No Abstract] [Full Text] [Related]
15. CT appearance of incidental pancreatic lipomas: a case series.
Hois EL; Hibbeln JF; Sclamberg JS
Abdom Imaging; 2006; 31(3):332-8. PubMed ID: 16705398
[TBL] [Abstract][Full Text] [Related]
16. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.
Higashi T; Sakahara H; Torizuka T; Nakamoto Y; Kanamori S; Hiraoka M; Imamura M; Nishimura Y; Tamaki N; Konishi J
J Nucl Med; 1999 Sep; 40(9):1424-33. PubMed ID: 10492360
[TBL] [Abstract][Full Text] [Related]
18. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
19. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience using a new integrated in-line PET/CT system.
Steinert HC; von Schulthess GK
Br J Radiol; 2002 Nov; 75 Spec No():S36-8. PubMed ID: 12519734
[No Abstract] [Full Text] [Related]
[Next] [New Search]